Biomechanical Properties and Their Association With Balance and Functional Mobility in Children With Cerebral Palsy
NCT ID: NCT05818839
Last Updated: 2023-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2022-07-01
2023-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relationship of Trunk Control and Endurance with Balance and Functional Mobility in Cerebral Palsy
NCT05158634
Walking Ability and Limit of Stability in Children With Spastic Cerebral Palsy
NCT05583929
Trunk Somatosensory Function, Trunk Control, and Thoracic Kyphosis in Children With Spastic Cerebral Palsy
NCT06697704
Assessment of Trunk Position Sense, Trunk Control, and Functional Independence in Children With Cerebral Palsy
NCT07347483
The Relationship Between Upper Extremity Functionality, Trunk Control and Balance in Children With Cerebral Palsy
NCT06378723
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
UCP
Children diagnosed with unilateral spastic cerebral palsy
No interventions assigned to this group
TyD
Typically developing children
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* spasticity level MAS≤2,
* mental level sufficient to understand commands given,
* and ambulation without the use of an orthosis or other device. In addition, children had to be GMFCS level I or II.
* aged between 4 and 12 years,
* no neurological or orthopaedic diagnosis,
* no known systemic problems,
* normal vision and hearing,
* and a mental level sufficient to understand the commands given.
Exclusion Criteria
* uncorrected vision or hearing problems,
* severe epileptic seizures,
* lower extremity contractures,
* botulinum toxin A injection in the previous six months,
* lower extremity surgery in less than one year,
* use of pharmacological agents that affect muscle tone,
* and poor cooperation.
4 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ilke KARA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ilke KARA
Co-Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Okan University
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BEU-CP-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.